CORONA, TIBERIO Statistiche
CORONA, TIBERIO
Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study
2019-01-01 Convertino, I; Leonardi, L; Tuccori, M; Ferraro, S; Salvadori, S; Franchini, M; De Carlo, I; Kirchmayer, U; Corona, T; Riengler, S; Menditto, E; Parrilli, M; Rossi, M; Orlando, V; Pieroni, S; Vannacci, A
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy
2018-01-01 Convertino, I; Salvadori, S; Pecori, A; Galiulo, Mt; Ferraro, S; Parrilli, M; Corona, T; Turchetti, G; Blandizzi, C; Tuccori, M
Anticoagulant Therapy in Patients with Atrial Fibrillation and Risk of Bleeding: Interim Analysis: Tyrion Study
2018-01-01 Ferraro, S; Convertino, I; Salvadori, S; Pieroni, S; Pecori, A; Franchini, M; De Carlo, I; Kirchmayer, U; Corona, T; Parrilli, M; Rossi, M; Vannacci, A; Blandizzi, C; Tuccori, M
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study
2017-01-01 Galiulo, M; Convertino, I; Blandizzi, C; Tassi, R; Diacciati, S; Nobili, S; Sansone, Ac; Marino, Aa; Mini, E; Mazzei, T; Vannacci, A; Parrilli, M; Corona, T; Tuccori, M
IntenSive Monitoring Program of TeratOgen and Non-Teratogen Risk of Drugs During Pregnancy: the STORK Project
2017-01-01 Tuccori, M; Convertino, I; Galiulo, M; Sansone, Ac; Mantarro, S; Marino, A; Vannacci, A; Parrilli, M; Corona, T; Blandizzi, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study | 1-gen-2019 | Convertino, I; Leonardi, L; Tuccori, M; Ferraro, S; Salvadori, S; Franchini, M; De Carlo, I; Kirchmayer, U; Corona, T; Riengler, S; Menditto, E; Parrilli, M; Rossi, M; Orlando, V; Pieroni, S; Vannacci, A | |
| A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy | 1-gen-2018 | Convertino, I; Salvadori, S; Pecori, A; Galiulo, Mt; Ferraro, S; Parrilli, M; Corona, T; Turchetti, G; Blandizzi, C; Tuccori, M | |
| Anticoagulant Therapy in Patients with Atrial Fibrillation and Risk of Bleeding: Interim Analysis: Tyrion Study | 1-gen-2018 | Ferraro, S; Convertino, I; Salvadori, S; Pieroni, S; Pecori, A; Franchini, M; De Carlo, I; Kirchmayer, U; Corona, T; Parrilli, M; Rossi, M; Vannacci, A; Blandizzi, C; Tuccori, M | |
| Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study | 1-gen-2017 | Galiulo, M; Convertino, I; Blandizzi, C; Tassi, R; Diacciati, S; Nobili, S; Sansone, Ac; Marino, Aa; Mini, E; Mazzei, T; Vannacci, A; Parrilli, M; Corona, T; Tuccori, M | |
| IntenSive Monitoring Program of TeratOgen and Non-Teratogen Risk of Drugs During Pregnancy: the STORK Project | 1-gen-2017 | Tuccori, M; Convertino, I; Galiulo, M; Sansone, Ac; Mantarro, S; Marino, A; Vannacci, A; Parrilli, M; Corona, T; Blandizzi, C |